Sign Out
Symptoms and Signs: In a bioavailability study, intranasal doses of up to 24 times the recommended daily adult dose were studied over three days with no adverse systemic effects observed (see Pharmacology: Pharmacokinetics under Actions).
Treatment: Acute overdose is unlikely to require any therapy other than observation.
